A discussion highlighted concerns regarding GHRP-6’s tendency to increase prolactin and cortisol levels alongside growth hormone. Users suggested that dopamine agonists might be needed to manage prolactin, and expressed concern that multiple daily doses could lead to peptide resistance over time.